AstraZeneca is stopping a clinical trial of the experimental drug volrustomig as it didn’t look set to help fight lung cancer better than existing therapies. The company had two separate late-stage trial successes that strengthen key cancer franchises, including one where patients with non-small...
Source: [Bloomberg Markets](https://www.bloomberg.com/news/videos/2026-08-17/astrazeneca-reports-mixed-lung-cancer-trial-results-video)